WBP2 was first discovered by our group to be associated with breast cancer in 2007 when it was shown by phosphoproteomic profiling to be hyperphosphorylated in an isogenic MCF-10AT breast cancer progression model comprising 4 isogenic xenograft-derived human cell lines that mimic different stages of breast cancer progression [10]. This evidence concerns the gene WBP2 and breast carcinoma.